SCHEMBL4166891

SCHEMBL4166891

NC(=O)[C@H](CCCSCC(=O)C(F)(F)F)NC(=O)Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.52
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
PTPN1 P18031 4/20 0.46
NPY1R P25929 1/20 0.41
CNR2 P34972 6/20 0.41
PADI1 Q9ULC6 3/20 0.41
PADI4 Q9UM07 3/20 0.41
PADI2 Q9Y2J8 2/20 0.41
PTPN2 P17706 1/20 0.40
PTPRA P18433 1/20 0.40
PTPN6 P29350 1/20 0.40
PTPN11 Q06124 1/20 0.40
PADI3 Q9ULW8 2/20 0.40
CHRNA1 P02708 1/20 0.39
CHRNG P07510 1/20 0.39
CHRNB1 P11230 1/20 0.39
CHRND Q07001 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4304780 0.98 CES1 (0.50) CES1HDAC1HDAC2PTPN1NPY1R
Trifluoroacetic Acid SCHEMBL4160622 0.85 PADI4 (0.39) CES1HDAC1HDAC2PTPN1PADI1
SCHEMBL4156447 0.82 CES1 (0.59) CES1HDAC1HDAC2PADI1PADI4
SCHEMBL4158065 0.82 CES1 (0.45) CES1HDAC1HDAC2NPY1RCNR2
SCHEMBL4605614 0.82 CES1 (0.45) CES1HDAC1HDAC2NPY1RCNR2
SCHEMBL4606734 0.81 NPY1R (0.46) CES1HDAC1HDAC2NPY1RPOLB
SCHEMBL4169033 0.80 CES1 (0.52) CES1HDAC1HDAC2CNR2
Trifluoroacetic Acid SCHEMBL4304781 0.78 CES1 (0.50) CES1HDAC1HDAC2CNR2
SCHEMBL9203772 0.77 ITGB3 (0.54) PTPN1NPY1RCNR2CHRNA1CHRNG
Trifluoroacetic Acid SCHEMBL4606072 0.76 SIGMAR1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 CES1 1925/4885HDAC1 2/4885HDAC2 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.